strontium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases non-vertebral fracture incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“A 37% reduction in vertebral fractures (RR 0.63, 95% CI 0.56, 0.71) and a 14% reduction in non-vertebral fractures (RR 0.86, 95% CI 0.75, 0.98) were demonstrated over three years with 2 g of strontium ranelate daily in a treatment population.”
Quoted verbatim from Strontium ranelate for preventing and treating postmenopausal osteoporosis.. - Study
- meta-analysis
- Dose
- strontium ranelate 2 g daily
- Population
- Postmenopausal women with osteoporosis (treatment population: prevalent vertebral fractures and/or lumbar spine BMD T score below -2.5 SD); pooled RCTs of strontium ranelate versus placebo; 2 g daily dose stratum, three years
Effect 0.86 risk ratio, 95% CI 0.75 to 0.98
Strontium ranelate for preventing and treating postmenopausal osteoporosis.2006PMID:17054253Permalink
Keep reading
- Everything the graph holds on strontium(2+)
- Every compound studied against Non-vertebral fracture incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5N0YHN4E2DPGMJWR4N4KYXZ